These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 38398062)

  • 1. L-DOS47 Elevates Pancreatic Cancer Tumor pH and Enhances Response to Immunotherapy.
    Jardim-Perassi BV; Irrera P; Oluwatola OE; Abrahams D; Estrella VC; Ordway B; Byrne SR; Ojeda AA; Whelan CJ; Kim J; Beatty MS; Damgaci-Erturk S; Longo DL; Gaspar KJ; Siegers GM; Centeno BA; Lau JYC; Pilon-Thomas SA; Ibrahim-Hashim A; Gillies RJ
    Biomedicines; 2024 Feb; 12(2):. PubMed ID: 38398062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L-DOS47 enhances response to immunotherapy in pancreatic cancer tumor.
    Jardim-Perassi BV; Irrera P; Abrahams D; Estrella VC; Ordway B; Byrne SR; Ojeda AA; Whelan CJ; Kim J; Beatty MS; Damgaci-Erturk S; Longo DL; Gaspar KJ; Siegers GM; Centeno BA; Lau JYC; Ibrahim-Hashim A; Pilon-Thomas SA; Gillies RJ
    bioRxiv; 2023 Aug; ():. PubMed ID: 37693389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Phase 1, Open-Label, Dose-Escalation Study of L-DOS47 in Combination With Pemetrexed Plus Carboplatin in Patients With Stage IV Recurrent or Metastatic Nonsquamous NSCLC.
    Piha-Paul S; Simon G; Belani CP; Chao H; Gaspar K; Lee B; Dowlati A
    JTO Clin Res Rep; 2022 Nov; 3(11):100408. PubMed ID: 36268537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and Characterization of a Camelid Single Domain Antibody-Urease Conjugate That Targets Vascular Endothelial Growth Factor Receptor 2.
    Tian B; Wong WY; Uger MD; Wisniewski P; Chao H
    Front Immunol; 2017; 8():956. PubMed ID: 28871252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production and characterization of a camelid single domain antibody-urease enzyme conjugate for the treatment of cancer.
    Tian B; Wong WY; Hegmann E; Gaspar K; Kumar P; Chao H
    Bioconjug Chem; 2015 Jun; 26(6):1144-55. PubMed ID: 25938892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraperitoneal Delivery of Iopamidol to Assess Extracellular pH of Orthotopic Pancreatic Tumor Model by CEST-MRI.
    Jardim-Perassi BV; Irrera P; Lau JYC; Budzevich M; Whelan CJ; Abrahams D; Ruiz E; Ibrahim-Hashim A; Damgaci Erturk S; Longo DL; Pilon-Thomas SA; Gillies RJ
    Contrast Media Mol Imaging; 2023; 2023():1944970. PubMed ID: 36704211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutralization of Tumor Acidity Improves Antitumor Responses to Immunotherapy.
    Pilon-Thomas S; Kodumudi KN; El-Kenawi AE; Russell S; Weber AM; Luddy K; Damaghi M; Wojtkowiak JW; Mulé JJ; Ibrahim-Hashim A; Gillies RJ
    Cancer Res; 2016 Mar; 76(6):1381-90. PubMed ID: 26719539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor pH Imaging Using Chemical Exchange Saturation Transfer (CEST)-MRI.
    Longo DL; Pirotta E; Gambino R; Romdhane F; Carella A; Corrado A
    Methods Mol Biol; 2023; 2614():287-311. PubMed ID: 36587132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a Nanoscale Chemical Exchange Saturation Transfer Magnetic Resonance Imaging Contrast Agent That Measures pH.
    Kombala CJ; Kotrotsou A; Schuler FW; de la Cerda J; Ma JC; Zhang S; Pagel MD
    ACS Nano; 2021 Dec; 15(12):20678-20688. PubMed ID: 34870957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiparametric chemical exchange saturation transfer MRI detects metabolic changes in breast cancer following immunotherapy.
    Hoffmann E; Schache D; Höltke C; Soltwisch J; Niland S; Krähling T; Bergander K; Grewer M; Geyer C; Groeneweg L; Eble JA; Vogl T; Roth J; Heindel W; Maus B; Helfen A; Faber C; Wildgruber M; Gerwing M; Hoerr V
    J Transl Med; 2023 Aug; 21(1):577. PubMed ID: 37641066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the Therapeutic Efficacy of Proton Transport Inhibitors in a Triple-Negative Breast Cancer Murine Model with Magnetic Resonance Imaging-Chemical Exchange Saturation Transfer Tumor pH Imaging.
    Dhakan C; Anemone A; Ventura V; Carella A; Corrado A; Pirotta E; Villano D; Romdhane F; Gammaraccio F; Aime S; Longo DL
    Metabolites; 2023 Nov; 13(11):. PubMed ID: 37999256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DPP inhibition alters the CXCR3 axis and enhances NK and CD8+ T cell infiltration to improve anti-PD1 efficacy in murine models of pancreatic ductal adenocarcinoma.
    Fitzgerald AA; Wang S; Agarwal V; Marcisak EF; Zuo A; Jablonski SA; Loth M; Fertig EJ; MacDougall J; Zhukovsky E; Trivedi S; Bhatia D; O'Neill V; Weiner LM
    J Immunother Cancer; 2021 Nov; 9(11):. PubMed ID: 34737215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Vivo Imaging of Tumor Metabolism and Acidosis by Combining PET and MRI-CEST pH Imaging.
    Longo DL; Bartoli A; Consolino L; Bardini P; Arena F; Schwaiger M; Aime S
    Cancer Res; 2016 Nov; 76(22):6463-6470. PubMed ID: 27651313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CEST-MRI for glioma pH quantification in mouse model: Validation by immunohistochemistry.
    Ferrauto G; Di Gregorio E; Auboiroux V; Petit M; Berger F; Aime S; Lahrech H
    NMR Biomed; 2018 Nov; 31(11):e4005. PubMed ID: 30256478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acidosis and cancer: from mechanism to neutralization.
    Ibrahim-Hashim A; Estrella V
    Cancer Metastasis Rev; 2019 Jun; 38(1-2):149-155. PubMed ID: 30806853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Translation of Tumor Acidosis Measurements with AcidoCEST MRI.
    Jones KM; Randtke EA; Yoshimaru ES; Howison CM; Chalasani P; Klein RR; Chambers SK; Kuo PH; Pagel MD
    Mol Imaging Biol; 2017 Aug; 19(4):617-625. PubMed ID: 27896628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Esomeprazole Treatment on Extracellular Tumor pH in a Preclinical Model of Prostate Cancer by MRI-CEST Tumor pH Imaging.
    Irrera P; Roberto M; Consolino L; Anemone A; Villano D; Navarro-Tableros V; Carella A; Dastrù W; Aime S; Longo DL
    Metabolites; 2022 Dec; 13(1):. PubMed ID: 36676972
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.